BackQuantum BioPharma Overview

Quantum BioPharma Receivables

Quantum BioPharma's receivables is $110K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$107504.00
↓ 96.67% YoYΔ $-3.12M vs prior year quarter

Peer trimmed avg / median

Loading

Quantum BioPharma Receivables History

Loading

Quantum BioPharma vs. peers: Receivables Comparison

Loading

Quantum BioPharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Quantum BioPharma (QNTM) FAQ

As of the most recent data (June 2026), QNTM shows a receivables of $110K. That compares with $3.2M in the prior-year period — down 96.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, QNTM's receivables is now $110K (was $3.2M) — a 96.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Quantum BioPharma is outperforming or lagging.

Tracking QNTM's receivables over time shows whether Quantum BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $110K That compares with $3.2M in the prior-year period — down 96.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Quantum BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $110K) with ownership activity and broader fundamentals.